Latest filings (excl ownership)
8-K
Results of Operations and Financial Condition
12 Apr 24
ARS
2023 FY
Annual report to shareholders
3 Apr 24
DEFA14A
Additional proxy soliciting materials
3 Apr 24
DEF 14A
Definitive proxy
3 Apr 24
8-K
Departure of Directors or Certain Officers
22 Mar 24
8-K
Other Events
18 Mar 24
25-NSE
Exchange delisting
15 Mar 24
424B2
Prospectus for primary offering
14 Mar 24
FWP
Free writing prospectus
13 Mar 24
424B5
Prospectus supplement for primary offering
13 Mar 24
8-K
Regulation FD Disclosure
27 Feb 24
8-K
Other Events
8 Feb 24
8-K
Other Events
31 Jan 24
8-K
Material Modifications to Rights of Security Holders
30 Jan 24
424B2
Prospectus for primary offering
26 Jan 24
FWP
Free writing prospectus
24 Jan 24
424B5
Prospectus supplement for primary offering
24 Jan 24
8-K
Results of Operations and Financial Condition
19 Jan 24
8-K
Other Events
21 Nov 23
424B2
Prospectus for primary offering
17 Nov 23
FWP
Free writing prospectus
16 Nov 23
FWP
Free writing prospectus
16 Nov 23
424B5
Prospectus supplement for primary offering
16 Nov 23
8-K
Regulation FD Disclosure
1 Nov 23
8-K
Departure of Directors or Certain Officers
30 Oct 23
10-Q
2023 Q3
Quarterly report
27 Oct 23
8-K
Record Cash Net Inflows of $41 Billion at Global Advisors
18 Oct 23
8-K
Regulation FD Disclosure
11 Sep 23
8-K
Other Events
3 Aug 23
424B2
Prospectus for primary offering
2 Aug 23
FWP
Free writing prospectus
31 Jul 23
FWP
Free writing prospectus
31 Jul 23
424B5
Prospectus supplement for primary offering
31 Jul 23
10-Q
2023 Q2
Quarterly report
28 Jul 23
8-K
Strong Flows In Asset Management
14 Jul 23
8-K
Other Events
7 Jun 23
S-8
Registration of securities for employees
19 May 23
8-K
Departure of Directors or Certain Officers
19 May 23
8-K
Other Events
18 May 23
424B2
Prospectus for primary offering
16 May 23
Latest ownership filings
SC 13G/A
bluebird bio, Inc.
10 Apr 24
SC 13G
C4 Therapeutics, Inc.
10 Apr 24
SC 13G/A
Replimune Group, Inc.
10 Apr 24
SC 13G
Biomea Fusion, Inc.
10 Apr 24
SC 13G/A
Altimmune, Inc.
10 Apr 24
SC 13G/A
Editas Medicine, Inc.
10 Apr 24
144
Notice of proposed sale of securities
8 Apr 24
SC 13G/A
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
11 Mar 24
SC 13G/A
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
11 Mar 24
4
Eric W. Aboaf
4 Mar 24
4
Anthony Bisegna
4 Mar 24
SC 13G/A
KILROY REALTY CORP
4 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
29 Feb 24
144
Notice of proposed sale of securities
29 Feb 24
4
Yie-Hsin Hung
27 Feb 24
4
JOHN PLANSKY
27 Feb 24
4
Anthony Bisegna
27 Feb 24
4
JOERG AMBROSIUS
27 Feb 24
4
Ian Appleyard
27 Feb 24
4
Kathryn M Horgan
27 Feb 24
4
HANLEY RONALD P O
27 Feb 24
4
Eric W. Aboaf
27 Feb 24
4
Ann Fogarty
27 Feb 24
4
BRIAN J FRANZ
27 Feb 24
4
W. Bradford Hu
27 Feb 24
4
Sarah Timby
27 Feb 24
4
Donna M Milrod
27 Feb 24
4
Donna M Milrod
26 Feb 24
4
HANLEY RONALD P O
22 Feb 24
144
Notice of proposed sale of securities
22 Feb 24
4
Sarah Timby
20 Feb 24
4
MOSTAPHA TAHIRI
20 Feb 24
4
JOHN PLANSKY
20 Feb 24
4
Donna M Milrod
20 Feb 24
4
HANLEY RONALD P O
20 Feb 24
4
Yie-Hsin Hung
20 Feb 24
4
W. Bradford Hu
20 Feb 24
4
Kathryn M Horgan
20 Feb 24
4
BRIAN J FRANZ
20 Feb 24